Premium Information is available for this item - Upgrade for $1 a day
5996-01-521-5947
Audio-Radio Frequency Amplifier
5996015215947 015215947 G641B00000-1
An electronic device whose audio and radio frequency input signals control power from a source independent of the input signals and delivers audio and radio frequency output signals of greater amplitude with respect to current and/or voltage. The output signals characteristics are uniformly related to the input signals. It operates at frequencies above and below 20 kilohertz. View more Audio-Radio Frequency Amplifier
January 2023
4
Marketplace 5996-01-521-5947
Request a Quotation from participating marketplace vendors
Related Documents 5996-01-521-5947 1+ Documents (More...)
Restrictions 5996-01-521-5947
5996-01-521-5947 is a Audio-Radio Frequency Amplifier that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is a US Munitions List or Commerce Control List Item which must be destroyed to prevent restoration or repair. Only authorized parties may possess this item. This item is not suspected to be hazardous. This item does not contain a precious metal.
Import and Export 5996-01-521-5947
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 5996-01-521-5947
- Germany (ZG01)
- Effective Date:
- 1 Jan 2015
Approved Sources 5996-01-521-5947
- Part Number
- Manufacturer
- Status
- G641B00000-1
- Manufacturer
- 05395 - L3harris Technologies Integrated (Active)
- Primary Buy
- Primary Buy
Datasheet 5996-01-521-5947
- Characteristic
- Specifications
- FIIG
- Specifications
- A32200
- End Item Identification [AGAV]
- Breguet 1150 Recon Aircraft
NATO Stock Numbers Related to 5996-01-521-5947
Freight Information 5996-01-521-5947
5996-01-521-5947 has freight characteristics.. 5996-01-521-5947 has a variance between NMFC and UFC when transported by rail and the description should be consulted.